Regulation 5 Revocations, savings and transitional provisionsI1
England and Wales
The instruments specified in column 1 of the table in Schedule 3 are revoked to the extent specified in column 3 of that table, subject to paragraph (2).
The instruments specified in column 1 of the table in Schedule 3 continue to have effect (so far as otherwise revoked to the extent specified in column 3 of that table)—
until 21 February 2021 in respect of infant formula and follow-on formula manufactured from protein hydrolysates;
for the purposes of paragraph (3)(b).
Infant formula and follow-on formula which does not comply with a specified EU law requirement may continue to be marketed until stocks of such food are exhausted, provided that—
it was placed on the market or labelled—
before 22 February 2020; or
before 22 February 2021 in the case of infant formula and follow-on formula manufactured from protein hydrolysates; and
the conditions specified in the following provision of the Infant Formula and Follow-on Formula (Wales) Regulations 2007 M1 are met—
regulation 3(1) (prohibition on the marketing of infant formula unless certain conditions are met) in the case of infant formula;
regulation 3(2) (prohibition on the marketing of follow-on formula unless certain conditions are met) in the case of follow-on formula.
Regulations 2 to 4 do not apply in respect of infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.
Schedule 4 makes provision in relation to infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.
Annotations
Textual amendments
- F1
Reg. 5(4)(5) inserted (16.9.2021) by The Infant Formula and Follow-on Formula (Wales) (Amendment) Regulations 2021 (S.I. 2021/955), regs. 1(2), 2(2)
Marginal citations
- M1
S.I. 2007/3573 (W. 316). The relevant amending instrument is S.I. 2008/2602 (W. 228).
Commencement
- I1
Reg. 5 in force at 22.2.2020 for specified purposes and at 22.2.2021 in so far as not already in force, see reg. 1(2)